CLINICAL_TRIALS
trial_result
· 2017-06-12
Clinical Trial Update: Japanese phase1 Study of Belimumab (IV vs SC) [Phase 1]
Summary
A Japanese Phase 1 study comparing intravenous and subcutaneous belimumab in systemic lupus erythematosus has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Systemic Lupus Erythematosus | Phase 1 | Status: COMPLETED